How many insider trades does FilingIQ track for QNRX?

FilingIQ tracks 25 Form 4 insider transactions for QNRX (Quoin Pharmaceuticals, Ltd.), covering filings from Jun 7, 2024 onwards. 6 of those were filed in the last 90 days.

Are QNRX insiders net buyers or net sellers?

Across the full Form 4 history for QNRX, 22 transactions (88%) were open-market purchases and 1 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does QNRX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is QNRX in?

Quoin Pharmaceuticals, Ltd. (QNRX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $15.85M.

QNRX insider trading

Healthcare

Quoin Pharmaceuticals, Ltd. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

88% / 4%

Market cap

$15.85M

About Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.

Company website: quoinpharma.com

QNRX insider activity at a glance

FilingIQ has scored 25 insider transactions for QNRX since Jun 7, 2024. The most recent filing in our index is dated Aug 31, 2026.

Across the full history, 22 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on QNRX insider trades is 70.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live QNRX trades on FilingIQ Raw filings on SEC EDGAR

Latest QNRX Form 4 filings

Myers Michael Chief Executive Officer

P Aug 31, 2026

Lawlor Sally Bridget Chief Financial Officer

P Aug 31, 2026

Carter Denise P. Chief Operating Officer

P Aug 31, 2026

Myers Michael Chief Executive Officer

P Dec 23, 2024

Carter Denise P. Chief Operating Officer

P Dec 23, 2024

Dunn Gordon Chief Financial Officer

P Dec 23, 2024

Dunn Gordon Chief Financial Officer

P Sep 10, 2024

Myers Michael Chief Executive Officer

P Sep 4, 2024

Carter Denise P. Chief Operating Officer

P Sep 4, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 805

UNITED THERAPEUTICS Corp

BLLN 188

BillionToOne, Inc.

KYMR 166

Kymera Therapeutics, Inc.

THERMO FISHER SCIENTIFIC INC.

HNGE 122

Hinge Health, Inc.

GH 120

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for QNRX?: FilingIQ tracks 25 Form 4 insider transactions for QNRX (Quoin Pharmaceuticals, Ltd.), covering filings from Jun 7, 2024 onwards. 6 of those were filed in the last 90 days.
Are QNRX insiders net buyers or net sellers?: Across the full Form 4 history for QNRX, 22 transactions (88%) were open-market purchases and 1 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does QNRX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is QNRX in?: Quoin Pharmaceuticals, Ltd. (QNRX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $15.85M.

Methodology & sources

Every QNRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.